Colgate-Palmolive Co. diskutieren

Hey there! After digging into Colgate-Palmolive, I've gotta say, I'm feeling pretty bullish. Sure, the energy sector's been a bit of a rollercoaster lately, but Colgate's like that trusty toothbrush you can always count on, you know? With all the uncertainty in the oil market, consumer staples like Colgate seem like a safe harbor. Plus, their valuation looks pretty sweet right now. It's like finding a tube of toothpaste on sale – who doesn't love a good deal? While the big oil guys are sweating over demand issues, Colgate's just chugging along, keeping our pearly whites shining. Might not be as exciting as a gushing oil well, but in these choppy waters, steady and reliable wins the race, right? So yeah, I'm thinking Colgate's got some room to grow. Just my two cents, though – always do your own homework!

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at JPMorgan Chase & Co. from $95.00 to $103.00. They now have an "overweight" rating on the stock.

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at Citigroup Inc. from $103.00 to $108.00. They now have a "buy" rating on the stock.

Colgate-Palmolive Company (NYSE: CL) had its price target lowered by analysts at UBS Group AG from $109.00 to $106.00. They now have a "buy" rating on the stock.

Colgate-Palmolive Company (NYSE: CL) had its price target lowered by analysts at Wells Fargo & Company from $88.00 to $83.00. They now have an "underweight" rating on the stock.

Colgate-Palmolive Company (NYSE: CL) had its price target lowered by analysts at Morgan Stanley from $104.00 to $96.00. They now have an "overweight" rating on the stock.

Colgate-Palmolive Company (NYSE: CL) had its price target lowered by analysts at JPMorgan Chase & Co. from $99.00 to $95.00. They now have an "overweight" rating on the stock.

Colgate-Palmolive Company (NYSE: CL) had its price target lowered by analysts at Citigroup Inc. from $108.00 to $105.00. They now have a "buy" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at Wells Fargo & Company from $83.00 to $80.00. They now have an "underweight" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $106.00 to $91.00. They now have a "buy" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at Bank of America Corporation from $98.00 to $88.00. They now have a "buy" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at JPMorgan Chase & Co. from $95.00 to $88.00. They now have an "overweight" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at Raymond James Financial, Inc. from $105.00 to $95.00. They now have an "outperform" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..

Colgate-Palmolive (NYSE:CL) had its "outperform" rating reaffirmed by analysts at Evercore ISI.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at Wells Fargo & Company from $80.00 to $77.00. They now have an "underweight" rating on the stock.

Colgate-Palmolive (NYSE:CL) was given a new $87.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at JPMorgan Chase & Co. from $88.00 to $87.00. They now have an "overweight" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target lowered by analysts at UBS Group AG from $92.00 to $90.00. They now have a "buy" rating on the stock.

Colgate-Palmolive (NYSE:CL) had its price target raised by analysts at JPMorgan Chase & Co. from $87.00 to $88.00. They now have an "overweight" rating on the stock.